BAM
MRNA icon

Byrne Asset Management’s Moderna MRNA Stock Holding History

Byrne Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-685
Closed -$91.4K – 176
2023
Q1 		$105K Sell
685
-18
-3% -$2.97K 0.08% 175
2022
Q4 		$126K Sell
703
-185
-21% -$30.2K 0.09% 159
2022
Q3 		$105K Sell
888
-63
-7% -$9.56K 0.08% 153
2022
Q2 		$136K Sell
951
-72
-7% -$10.3K 0.1% 124
2022
Q1 		$176K Sell
1,023
-199
-16% -$33.5K 0.11% 118
2021
Q4 		$310K Buy
+1,222
New +$357K 0.2% 95

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Byrne Asset Management's MRNA Position: Q2 2023 in Review

Byrne Asset Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 685 shares — an estimated $91.4K sold.

Byrne Asset Management first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $310K in Q4 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Byrne Asset Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Byrne Asset Management sold 685 Moderna shares in Q2 2023, an estimated $91.4K.
  • Byrne Asset Management first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Byrne Asset Management's Moderna position peaked at $310K in Q4 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Byrne Asset Management's 13F filing for Q2 2023, filed 21 Jul 2023.